RxDoctor Payments Data

Richard Winne, MD

Anesthesiology · Morristown, NJNPI 1134125743

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 70.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $10,505 and has fallen 98.6% since, to $148 in 2025. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,646in general payments, 2019–2025

Across 190 payments — averaging $77.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$10K
  • Nalu Medical, Inc.$2K
  • Medtronic$729
  • Abbott$436
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$341
  • Boston Scientific$244
  • plus $890 from 18 others

What the payments were for

  • Consulting fees$2,00014%
  • Speaking & faculty fees$7,25050%
  • Travel & lodging$1,3239%
  • Food & beverage$4,07328%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,646 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$219,174
Medicare patients
419
Services billed
1,489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate41$38,471
OxycontinOxycodone Hcl27$30,021
Gabapentin334$7,155
Fentanyl25$2,500
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen105$2,023
Duloxetine Hcl81$1,790
Pregabalin56$1,525
Oxycodone Hcl56$1,234
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$1,216
Tramadol Hcl163$1,076
Hydromorphone Hcl23$570
Morphine Sulfate ErMorphine Sulfate25$430
Methylprednisolone55$414
Celecoxib20$308
Alprazolam32$298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$90$38,47141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

Other anesthesiology in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →